NCT01902667

Brief Summary

This is a prospective observational study in which patients with untreated retroperitoneal sarcoma will have Magnetic Resonance Imaging (MRI) prior to surgery. In addition, patients who will be undergoing pre-operative radiotherapy will have an additional MRI scan at two weeks post radiotherapy. For both groups, the magnetic resonance images will be correlated with tumour pathology. The study hypothesis is that Magnetic Resonance Imaging will provide a more accurate assessment of tumour volume and local staging than CT and will identify areas of altered oxygenation, cellularity and perfusion which change in response to radiotherapy before tumour shrinkage occurs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 18, 2013

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2017

Completed
Last Updated

August 8, 2018

Status Verified

August 1, 2018

Enrollment Period

4 years

First QC Date

July 9, 2013

Last Update Submit

August 7, 2018

Conditions

Keywords

Retroperitoneal SarcomaMagnetic Resonance Imaging

Outcome Measures

Primary Outcomes (1)

  • Prediction, by MRI, of early response to radiotherapy prior to tumour shrinkage

    Changes in volume, maximum axial diameter, ADC, F, D, D\*, T2, R2\* and enhancing fraction from baseline to post radiotherapy will be presented. A paired T-test (or Wilcoxon Signed Rank Test) may be used to test the difference between baseline and post radiotherapy. Differences in these values will be presented for responders and non-responders, which will be tested by independent T-test. Response will be determined by tumour size, enhancing fraction and histopathological evidence of response.

    2-4 weeks

Secondary Outcomes (1)

  • To determine the reproducibility of multi-parametric MRI measurements within tumour regions of interest in patients with retroperitoneal sarcoma.

    1-7 days

Other Outcomes (1)

  • Correlation of imaging features with histopathological assessment of tumour size, local staging, cellularity, necrosis and viable tumour.

    2 months

Study Arms (2)

Curative intent surgery alone

Patients with retroperitoneal sarcoma randomised into surgery alone arm.

Procedure: Magnetic Resonance Imaging

Pre-operative radiotherapy plus surgery

Patients with retroperitoneal sarcoma randomised to Arm 2: pre-operative radiotherapy plus surgery.

Procedure: Magnetic Resonance Imaging

Interventions

Curative intent surgery alonePre-operative radiotherapy plus surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with retroperitoneal sarcoma randomised for preoperative radiotherapy plus surgery versus surgery alone.

You may qualify if:

  • Patients with retroperitoneal sarcomas planned for surgical resection +/- preoperative radiotherapy.

You may not qualify if:

  • MRI incompatible metal implants
  • claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Marsden NHS Foundation Trust

Sutton, Surrey, SM2 5PT, United Kingdom

Location

Related Publications (1)

  • Winfield JM, Miah AB, Strauss D, Thway K, Collins DJ, deSouza NM, Leach MO, Morgan VA, Giles SL, Moskovic E, Hayes A, Smith M, Zaidi SH, Henderson D, Messiou C. Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With Histopathology. Front Oncol. 2019 Apr 25;9:280. doi: 10.3389/fonc.2019.00280. eCollection 2019.

MeSH Terms

Conditions

Neoplasms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Translational Imaging

Study Record Dates

First Submitted

July 9, 2013

First Posted

July 18, 2013

Study Start

July 1, 2013

Primary Completion

June 30, 2017

Study Completion

June 30, 2017

Last Updated

August 8, 2018

Record last verified: 2018-08

Locations